Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06073457 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Magnetic Gastro-Ileal or Gastro-Jejunal Diversion Study ("MGI/MGJ Study")

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Mar 2026 to Apr 17, 2026
    • Site details revised at 4 of 4 sites
    v8
  2. Study sites: 3 to 4
    • Primary completion date: Dec 2025 to Mar 2026
    • Study completion date: Feb 2027 to Jan 2027
    v7
  3. Study sites: 2 to 3
    • Primary completion date: Nov 2025 to Dec 2025
    • Study completion date: Oct 2026 to Feb 2027
    v6
  4. Primary completion date: Jul 2025 to Nov 2025
    • Study completion date: Dec 2025 to Oct 2026
    v5
  5. Study sites: 1 to 2
    • Primary completion date: Jul 30, 2025 to Jul 2025
    • Study completion date: Sep 30, 2025 to Dec 2025
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Oct 30, 2024 to Jul 30, 2025
    • Study completion date: Apr 30, 2025 to Sep 30, 2025
    • Start date changed from estimate of Oct 31, 2023 to Nov 6, 2023
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
GT Metabolic Solutions, Inc.
11 trials monitored
See 1 trial at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Obesity
3,874 trials monitored
See 152 trials at risk
Type 2 Diabetes
2,231 trials monitored
See 111 trials at risk
The purpose of this clinical research study is to evaluate the feasibility of the GT Metabolic Solutions Magnet System, GJ Biofragmentable ("MagGJ System") for creation of a side-to-side anastomosis for gastro-ileal or gastro-jejunal diversion in obese adults.
Trial Details
NCT Number NCT06073457
Lead Sponsor GT Metabolic Solutions, Inc.
Conditions
(from sponsor)		 Obesity, Type 2 Diabetes
Related terms Diabetes Mellitus, Type 2, Obesity
Enrollment 35 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov